Transformed Non-Hodgkin Lymphoma
specificHistologic transformation of a usually indolent non-Hodgkin lymphoma to an aggressive non-Hodgkin lymphoma.
17
Centers
17
Active Trials
—
Cancer Funding
Top Centers for Transformed Non-Hodgkin Lymphoma(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 52.9 |
| 2 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 52.9 |
| 3 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 52.9 |
| 4 | NCI Comprehensive Active Research Program | 52.9 |
| 5 | NCI Comprehensive Active Research Program | 52.9 |
| 6 | NCI Comprehensive Active Research Program | 52.9 |
| 7 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 52.9 |
| 8 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 52.9 |
| 9 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 52.9 |
| 10 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 52.9 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 52.9 |
| 12 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 52.9 |
| 13 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 52.9 |
| 14 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 52.9 |
| 15 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 52.9 |
| 16 | University of Illinois Cancer CenterChicago, IL Active Research Program | 52.9 |
| 17 | Cancer Center at IllinoisUrbana, IL Active Research Program | 52.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →